InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,815.03
(
0.61%
)
US TECH 100
19,756.40
(
0.11%
)
Dow Jones
42,863.86
(
0.97%
)
Brent Oil
77.69
(
0.28%
)
Bitcoin
64,423.60
(
2.50%
)
Post# of 19309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 840
Posts 120561
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: wjlknew post# 9470

Thursday, 03/27/2008 9:16:51 AM

Thursday, March 27, 2008 9:16:51 AM

Post# of 19309
PIP expects to submit the Protexia IND in 3Q08 and start a phase-1 trial in 4Q08 (#msg-27390930). Hence, PIP’s manufacturing process—and the need for GTC’s consultation—ought to be complete by then.

If Protexia makes it to market, GTC stands to earn a small royalty on sales (#msg-27957879, bottom).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up